Bionaturis’ FLYLIFE gala day

About thirty managers belonging to different institutions have visited Bionaturis’  FLYLIFE factory this week. The visit was part of the biotech committee of Corporacion Tecnologica of Andalusia (CTA). Reference people of the biotech sector including members of the Brazilian multinational company Ourofino or Bionaturis’ scientific advisor, professor Vikram Vakharia of Maryland University, among others, have been guided by Bionaturis’ staff to know at first hand how thousands of vaccines can be manufactured in no more than 350 square meters. The secret of Flylife is based on the use of butterfly caterpillars as natural factories to get these cutting-edge vaccines, allowing that more people and producers all over the world may have access to them.

About the visit, Javier Gallastegui -managing director of the company- claims “welcoming these personalities and friends and showing them how we take those vaccines to the world from Jerez is an honor for us”. Nowadays, several multinational companies that work in veterinarian field are evaluating vaccines produced by FLYLIFE technology, representing an outstanding milestone for Spanish Biotechnology.

Juan Jose Infante’s speech

Bionaturis, co-organizer of the committee along with CTA, took part with the conference titled ‘Second Generation Vaccines: Bionaturis’ Strategy’, in which the CSO, Juan Jose Infante, talked about the main vaccines being developed by Bionaturis so far. Infante has pointed out the relevance of the innovation in the research of vaccines and how they are key elements not only to human, but also to animal health in order to control devastating pandemics. A sustainable and more affordable manufacturing and developing process is essential to guarantee a broad access to high-benefit vaccines, something that Bionaturis gets with its platform FLYLIFE.

Corporacion Tecnologica of Andalusia (CTA) is a private foundation promoted by the […]

BNT at Loyola Leadership School: « Our quest is a global access to biological drugs, using innovation as the main driver »

Last April the 10th, the “Universidad Loyola de Andalucia” became the scene of a enriching discussion on successful practices of business model based on innovation.
« Corporacion Tecnologica de Andalucia (CTA) » organized the Technical Committee «Successful cases of business innovation in Andalusia » to share the experience and benefits of the business strategy envisaged by companies such as Wellness Telecom, Indra, Endesa, Caja Rural del Sur, Cosentino, Abengoa Solar NT, and Bionaturis. Any of these enterprises share a common feature: the culture of innovation. In a highly competitive market, to face up the ever-changing global environment, the innovation is used as a differentiation element that enables a sustainable competitive advantage. In this way, Victor Infante, CEO of Bionaturis described how the innovation is part of the DNA of the company: “while preserving the core, we stimulate the progress throughout innovation”.
Could you imagine a world with a fairer access to state-of-the-art drugs? Nowadays, 90% of worldwide expenditure on health research and development is devoted to the problems that primarily affect the 10% of the world’s population. Our endeavor is to balance this gap, using proprietary technology such as FLYLIFE©.
“We adapt early-stage biological drug leads, many of them obtained from academia, to the market specific requirements dictated by large pharmaceutical and veterinarian corporations”

Infante added: « Thus, we close the innovation chain, adding value to assets developed in public scientific groups but at the same time bringing real solutions to the market. FLYLIFE© makes possible that these high-performance drugs reach more patients and producers around the world».

CTAndalucia will hold the internal committee "Andalusian successful business cases"

Next Wednesday, our CEO Victor Manuel Infante, will talk about us within the internal committee organized by Corporacion Tecnologica de Andalucia at Seville.

April 8th, 2013|congress|0 Comments|

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.